Healthy potentially undervalued

Results

2475

Companies which are potentially undervalued and in an acceptable financial position.

2475 companies

	Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield	Industry
	CDA	€20.95	-5.6%	-0.2%	€1.1b	€27.28	9.0	3.1%	5.3%	Consumer Services
	IMG	CA$21.30	1.0%	115.6%	CA$12.2b	CA$33.55	8.7	8.2%	n/a	Materials
	TCW	CA$6.78	3.2%	21.3%	CA$1.4b	CA$8.32	12.9	7.0%	3.2%	Energy
	BZ	US$15.40	3.4%	-22.6%	US$7.1b	US$20.75	13.8	6.4%	1.1%	Commercial Services
	LOUP	€114.80	-1.0%	21.5%	€4.0b	€138.00	12.4	4.2%	2.0%	Food, Beverage & Tobacco
	TESB	€20.90	2.2%	-24.1%	€1.2b	€25.50	0.4	74.6%	3.6%	Materials
	FOUR	UK£39.58	4.7%	7.4%	UK£1.1b	UK£49.12	13.1	-5.3%	4.5%	Media
	HITI	CA$3.04	-0.7%	-6.7%	CA$273.3m	CA$7.30	0.4	65.6%	n/a	Pharmaceuticals & Biotech
	GPP	zł48.55	5.4%	-26.4%	zł3.3b	zł59.32	14.1	8.4%	6.2%	Commercial Services
	TCL.A	CA$5.45	-2.2%	-73.1%	CA$466.5m	CA$7.17	2.9	-30.8%	3.7%	Materials
	FGR	€122.75	0.6%	4.7%	€11.7b	€160.21	11.4	7.3%	3.9%	Capital Goods
	ICG	UK£18.49	-2.1%	-12.9%	UK£5.1b	UK£24.86	10.6	11.0%	4.7%	Diversified Financials
	GAMA	UK£9.60	1.9%	-10.2%	UK£858.8m	UK£14.01	13.2	3.5%	2.3%	Telecom
	EN	€48.30	0.08%	25.0%	€18.6b	€59.03	15.5	10.0%	4.3%	Capital Goods
	ATMU	US$52.53	2.0%	36.8%	US$4.2b	US$66.40	20.3	11.1%	0.4%	Capital Goods
	TRLV	US$8.67	0.5%	95.3%	US$1.7b	US$18.71	1.4	131.9%	n/a	Pharmaceuticals & Biotech
	DEME	€169.00	-2.3%	28.4%	€4.3b	€221.75	12.3	4.7%	2.7%	Capital Goods
	FLOC	US$20.66	2.2%	4.6%	US$1.8b	US$31.22	20.3	37.9%	1.7%	Energy
	XP	US$17.30	2.5%	2.0%	US$8.7b	US$23.55	8.6	11.5%	1.1%	Diversified Financials
	INF	€38.10	-4.0%	0.8%	€260.6m	€51.55	16.1	13.4%	5.2%	Software
	SSRM	CA$39.57	3.4%	128.7%	CA$8.0b	CA$59.45	10.4	11.1%	0%	Materials
	LKNC.Y	US$32.26	-0.2%	-13.8%	US$10.3b	US$45.71	19.7	22.1%	n/a	Consumer Services
	OSB	UK£5.58	0.9%	-0.6%	UK£1.9b	UK£6.78	6.9	6.0%	6.3%	Diversified Financials
	LKQ	US$25.19	1.1%	-34.8%	US$6.3b	US$40.13	12.5	14.4%	4.8%	Retail

Page 1 of 69